VITUS Post-Market Registry

RecruitingOBSERVATIONAL
Enrollment

284

Participants

Timeline

Start Date

May 22, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2029

Conditions
Peripheral Arterial DiseasePeripheral Arterial Occlusive Disease
Interventions
DEVICE

Percutaneous Transluminal Angioplasty with a paclitaxel drug-coated balloon

Balloon angioplasty for the treatment of symptomatic peripheral arterial disease with a paclitaxel drug-coated balloon

Trial Locations (9)

1800

RECRUITING

AZ Jan Portaels, Vilvoorde

3300

RECRUITING

RZ Heilig Hart Tienen, Tienen

9200

RECRUITING

AZ Sint-Blasius, Dendermonde

9300

RECRUITING

AZORG, Aalst

32005

RECRUITING

Complejo Hospitalario Universitario de Ourense, Ourense

32756

RECRUITING

Klinikum Lippe Detmold, Detmold

45007

RECRUITING

Hospital Universitario de Toledo, Toledo

76307

RECRUITING

SRH Klinikum Karlsbad-Langensteinbach GmbH, Karlsbad

08402

RECRUITING

Hospital General de Granollers, Granollers

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Eucatech AG

INDUSTRY

collaborator

Centre Européen de Recherche Cardiovasculaire

UNKNOWN

lead

OrbusNeich

INDUSTRY

NCT06832631 - VITUS Post-Market Registry | Biotech Hunter | Biotech Hunter